Furthermore, METTL16 has been implicated in a large number of cancer studies with both oncogenic and tumor-suppressive effects associated with changes in METTL16 expression levels [43,44,45,46,61,62,63,64,65,66,67,68,69,70,71,72,73]. The gene discussed is METTL16; the disease is cancer.